XML 45 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statement of Operations - EUR (€)
€ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Consolidated Statement of Operations      
Product net sales € 14,753 € 2  
Collaboration revenues 470,093 478,051 € 834,901
Total net revenues 484,846 478,053 834,901
Cost of sales (1,629)    
Research and development expenses (491,707) (523,667) (420,090)
Sales and marketing expenses (69,956) (66,468) (24,577)
General and administrative expenses (140,899) (118,757) (72,382)
Other operating income 53,749 52,207 50,896
Operating income/loss (-) (165,596) (178,632) 368,748
Fair value re-measurement of share subscription agreement and warrants 2,960 3,034 (181,644)
Other financial income 70,548 18,667 21,389
Other financial expenses (30,911) (152,844) (59,968)
Income/loss (-) before tax (122,999) (309,775) 148,525
Income taxes (2,423) (1,226) 165
Net income/loss (-) from continuing operations (125,422) (311,001) 148,689
Net income from discontinued operations, net of tax 22,191 5,565 1,156
Net income/loss (-) (103,231) (305,436) 149,845
Net income/loss (-) attributable to:      
Owners of the parent € (103,231) € (305,436) € 149,845
Basic income/loss (-) per share € (1.58) € (4.69) € 2.60
Diluted income/loss (-) per share (1.58) (4.69) 2.49
Basic income/ loss (-) per share from continuing operations (in EUR per share) (1.91) (4.78) 2.58
Diluted income/ loss (-) per share from continuing operations (in EUR per share) € (1.91) € (4.78) € 2.47